<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJCD</journal-id><journal-title-group><journal-title>Open Journal of Clinical Diagnostics</journal-title></journal-title-group><issn pub-type="epub">2162-5816</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojcd.2022.122003</article-id><article-id pub-id-type="publisher-id">OJCD-116857</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Histiocytic Necrotizing Lymphadenitis: A Clinical Study of 6 Children and Review
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yeling</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Feng</surname><given-names>Zhang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tuanmei</surname><given-names>Wang</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Hunan University of Chinese Medicine, Changsha, China</addr-line></aff><aff id="aff2"><addr-line>Department of Pediatric, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China</addr-line></aff><aff id="aff3"><addr-line>Changsha Hospital for Maternal &amp;amp; Child Health Care, Changsha, China</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>04</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>19</fpage><lpage>26</lpage><history><date date-type="received"><day>16,</day>	<month>March</month>	<year>2022</year></date><date date-type="rev-recd"><day>25,</day>	<month>April</month>	<year>2022</year>	</date><date date-type="accepted"><day>28,</day>	<month>April</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective
  : As a rare cause of fever and lymphadenopathy (especially in the neck) in children, the purpose of this study is to explore the clinical characteristics of histiocytic necrotizing lymphadenitis (HNL) in children and improve the diagnosis and treatment of this disease. 
  Methods: We retrospectively collected the data of 6 pediatric patients with HNL diagnosed by lymph node biopsy from 2012 to 2021 in department of pediatric, the affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, including the clinical characteristics, laboratory examinations, imaging findings and histopathological examinations, treatment and follow-up of the patients and reviewed relevant literature. 
  Results: All the patients were Han girls, with no kinship with each other, and four cases were from rural areas. The age of onset was from 7 to 14 years old, with durations ranged from 1 week to 3 months. All children had cervical lymphadenopathy with tenderness, five cases of fever, two cases of cough, one case of weight loss, four cases of leukopenia, one case of liver impairment, one case of combined bacterial infection of leukocytosis. All children underwent lymph node biopsy and were diagnosed with HNL, four children were treated with anti-infection before diagnosis, two children were treated with steroid therapy after diagnosis, and 1 case of weakened immune function was used immunoglobulin for modulating immunity. All children improved and discharged, and no recurrence was observed until October 2021. 
  Conclusion: In our study, the children with swollen lymph nodes in the neck were accompanied by tenderness and fever as the main clinical manifestations, without specificity. Histopathology and immunohistochemical examination by removing the affected lymph nodes could confirm HNL. Most children had a good prognosis and long-term follow-up were required.
 
</p></abstract><kwd-group><kwd>Kikuchi-Fujimoto Disease</kwd><kwd> Histiocytic Necrotizing Lymphadenitis</kwd><kwd> Children</kwd><kwd> Literature Review</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Histiocytic necrotizing lymphadenitis (HNL), also known as Kikuchi-Fujimoto disease (KFD), is a rare benign and self-limiting disease. This disease was first discovered in Japan in 1972 by Kikuchi and Fujimoto. The etiology and pathogenesis are unknown [<xref ref-type="bibr" rid="scirp.116857-ref1">1</xref>]. According to researches in this field, the possible cause of KFD is considered to be caused by viral infection or autoimmunity [<xref ref-type="bibr" rid="scirp.116857-ref2">2</xref>]. The course of the disease ranges from a few weeks to several months. The main manifestations of HNL are fever, lymphadenopathy (mainly in the neck), leukopenia, and reports of atypical symptoms such as rash, headache, night sweats, weight loss, and nervous system symptoms [<xref ref-type="bibr" rid="scirp.116857-ref3">3</xref>]. HNL is rare in the clinic, and there is no specific clinical manifestations, imaging and laboratory results, so it is easy to be misdiagnosed as upper respiratory tract infection, lymphadenitis, scrofula, malignant lymphoma, infectious mononucleosis and autoimmunity diseases such as systemic lupus erythematosus (SLE). Therefore, we collected the data of children with HNL diagnosed in our hospital and studied in combination with relevant literature to improve our understanding of the disease.</p></sec><sec id="s2"><title>2. Material and Methods</title><p>We retrospectively collected the data of 6 pediatric patients with HNL diagnosed by lymph node biopsy from 2012 to 2021 in department of pediatric, the affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, including the clinical characteristics, laboratory examinations, imaging findings and histopathological examinations, treatment and follow-up of the patients and reviewed relevant literatures.</p><p>Statistical analyses: continuous variables were presented as mean and 95% CI or median and interquartile range, while categorical variables were described using sample counts and percentages.</p></sec><sec id="s3"><title>3. Results</title><p>Among the 6 children, they were not related to each other. The age of onset was from 7 to 14 years old, the median age of onset was 13 years old, the course of illness varied from 1 week to 3 months, and the median time of onset was 10.5 days. Two of the 6 children had a history of cervical lymph node tuberculosis confirmed by lymph node biopsy, and they completed regular and adequate anti-tuberculosis treatment. Four cases had leukopenia, one case had liver damage (increased alanine aminotransferase and aspartate aminotransferase), one case had leukocytosis combined Burkholderia cepacia, three cases had elevated erythrocyte sedimentation rate (ESR) without anemia or thrombocytopenia. All children underwent tuberculosis-related examinations (such as TST, AFB, GeneXpert MTB/RIF, T-SPOT.TB) and those were negative. All children had Epstein-Barr virus serological examination, one was positive and combined with adenovirus infection. Four cases of autoimmune disease tests (such as antinuclear antibodies, rheumatic factors) showed negative, and HIV examinations were all negative. Three cases of bone marrow puncture ruled out blood system diseases. Ultrasound of cervical lymph nodes in all children showed that cervical lymph nodes were enlarged, some of which were combined with enlarged axillary, inguinal or abdominal lymph nodes. All children underwent lymph node biopsy and were diagnosed with HNL, and 5 cases underwent immunohistochemistry (the remaining 1 case was because our hospital had not yet implemented immunohistochemistry technology at the time). (<xref ref-type="fig" rid="fig1">Figure 1</xref>: Histologic findings include cortical or paracortical areas presenting varying degrees of coagulative necrosis with abundant karyorrhectic debris, and a large number of different types of histiocytes and immunoblasts surrounding the margin of necrotic areas. Immunophenotypically, a predominance of T cells.) Four children were treated with anti-infective treatment before diagnosis, two children were treated with steroid therapy after diagnosis, including 1 case of oral prednisone and 1 case of intravenous methylprednisolone, and 1 case of weakened immune function was used immunoglobulin for modulating immunity. All the children were improved and discharged, and no recurrence occurred during follow-up. Detailed clinical characteristics were shown in <xref ref-type="table" rid="table1">Table 1</xref>, and laboratory informations were shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of KFD in six children</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >Case 1</th><th align="center" valign="middle" >Case 2</th><th align="center" valign="middle" >Case 3</th><th align="center" valign="middle" >Case 4</th><th align="center" valign="middle" >Case 5</th><th align="center" valign="middle" >Case 6</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Female</td></tr><tr><td align="center" valign="middle" >Residence zone</td><td align="center" valign="middle" >Country</td><td align="center" valign="middle" >Country</td><td align="center" valign="middle" >City</td><td align="center" valign="middle" >City</td><td align="center" valign="middle" >Country</td><td align="center" valign="middle" >Country</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >Yes (a week)</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes (2 days)</td><td align="center" valign="middle" >Yes (8 days)</td><td align="center" valign="middle" >Yes (12 days)</td><td align="center" valign="middle" >Yes (a week)</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes (3 kg in a week)</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Cough</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Duration of cervical lymph node welling</td><td align="center" valign="middle" >A week</td><td align="center" valign="middle" >3 months</td><td align="center" valign="middle" >9 days</td><td align="center" valign="middle" >8 days</td><td align="center" valign="middle" >12 days</td><td align="center" valign="middle" >A month</td></tr><tr><td align="center" valign="middle" >Past medical history</td><td align="center" valign="middle" >Tuberculous lymphadenitis</td><td align="center" valign="middle" >Health</td><td align="center" valign="middle" >Health</td><td align="center" valign="middle" >Health</td><td align="center" valign="middle" >Tuberculous lymphadenitis, weakened immune function</td><td align="center" valign="middle" >Health</td></tr><tr><td align="center" valign="middle" >Physical examination</td><td align="center" valign="middle" >Enlarged bilateral cervical lymph nodes, tenderness, fixed, firm</td><td align="center" valign="middle" >Enlarged right cervical lymph nodes, tenderness, fixed, firm</td><td align="center" valign="middle" >Enlarged left cervical lymph nodes, tenderness</td><td align="center" valign="middle" >Enlarged left cervical lymph nodes, tenderness</td><td align="center" valign="middle" >Enlarged right cervical lymph nodes, tenderness, fixed, firm, skin temperature rise</td><td align="center" valign="middle" >Enlarged bilateral cervical lymph nodes, tenderness</td></tr><tr><td align="center" valign="middle" >Use antibiotics before diagnosis?</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Infection or not</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Epstein-Barr virus, adenovirus</td><td align="center" valign="middle" >Burkholderia diminuta</td><td align="center" valign="middle" >No</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Laboratory results of KFD in six children</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Laboratory Parameter</th><th align="center" valign="middle" >WBC (&#215;10<sup>9</sup>/L)</th><th align="center" valign="middle" >HB (g/L)</th><th align="center" valign="middle" >PLT (&#215;10<sup>9</sup>/L)</th><th align="center" valign="middle" >ESR (mm/h)</th></tr></thead><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >1.56 - 15.78</td><td align="center" valign="middle" >83.00 - 135.00</td><td align="center" valign="middle" >72.00 - 432.00</td><td align="center" valign="middle" >14.00 - 85.00</td></tr><tr><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >5.22</td><td align="center" valign="middle" >111.80</td><td align="center" valign="middle" >207.83</td><td align="center" valign="middle" >37.40</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >3.30</td><td align="center" valign="middle" >110.90</td><td align="center" valign="middle" >180.50</td><td align="center" valign="middle" >33.00</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>Since Kikuchi-Fujimoto disease was first discovered in Japan, more and more researchers have joined the research on this disease. Based on literature study, among adults, HNL is predominantly female, with a ratio of 4:1 [<xref ref-type="bibr" rid="scirp.116857-ref4">4</xref>]. However, studies on children find that the ratio of males is larger, with a ratio of 1.13:1, and the average age of children range from 11 to 13.2 years [<xref ref-type="bibr" rid="scirp.116857-ref3">3</xref>]. The average age in this study was similar with that reported in literatures but the subjects were all girls, which might be due to the lack of comprehensiveness of the data.</p><p>There are currently two most common viewpoints of its etiology: viral infection and autoimmunity. HNL clinical manifestations and antibiotics are similar to viral infections. Posterior cervical lymphadenopathy (mainly unilateral and V zone) and fever are the main clinical manifestations of KFD [<xref ref-type="bibr" rid="scirp.116857-ref5">5</xref>], and rare symptoms include weight loss, nausea, vomiting, rash, and upper respiratory symptoms [<xref ref-type="bibr" rid="scirp.116857-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.116857-ref7">7</xref>]. However, there was only one patient with viral infection in this study, and there was no research on the direct relationship between viral infections and KFD [<xref ref-type="bibr" rid="scirp.116857-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.116857-ref9">9</xref>]. In addition, there are reports that KFD is related to many autoimmune diseases, such as SLE, dry syndrome, Wegener granuloma, etc. [<xref ref-type="bibr" rid="scirp.116857-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.116857-ref11">11</xref>]. The researchers find that HNL patients are mainly concentrated in Asia, with certain genetic susceptibility. KFD enables T cells to induce immune responses to multiple antigens in gene susceptible individuals, and the study of KFD patients find that they often carry human white blood cells DPA1 and DPB1 of the antigens (HLA) II alleles [<xref ref-type="bibr" rid="scirp.116857-ref12">12</xref>].</p><p>For most children with cervical lymphadenopathy, ultrasound is the best diagnostic tool because it has no radiation and is non-invasive. When the affected lymph nodes are examined by ultrasound, hypoechoic foci are visible, and thick and irregular hyperechoic rings are visible on the outside [<xref ref-type="bibr" rid="scirp.116857-ref10">10</xref>]. However, ultrasonography is of limited value in the internal necrosis of lymph nodes, but CT scans can show extensive gross necrosis of diseased lymph nodes. The most common CT features of KFD in children are multiple, small, medium oval lymph nodes and round lymph node clusters related to internal necrosis [<xref ref-type="bibr" rid="scirp.116857-ref13">13</xref>]. <sup>18</sup>F-FDG PET/CT may be useful in assessing KFD severity [<xref ref-type="bibr" rid="scirp.116857-ref14">14</xref>]. In terms of laboratory examination, children with KFD mostly showed decreased white blood cells and neutrophil counts. In addition, some children had abnormal liver enzymes and elevated ESR [<xref ref-type="bibr" rid="scirp.116857-ref3">3</xref>], which was consistent with the laboratory performance of children in this study. However, these manifestations are not specific.</p><p>As a self-limiting disease, most of KFD is currently diagnosed by histopathology and immunohistochemical examination of the affected lymph nodes. Involved lymph nodes are usually isolated, solid, mobile, painful but not purulent. Histologically, the lesions of the lymph nodes are mainly concentrated in the paracortical area, the structure of the lymph nodes is missing, the necrotic foci show a great deal of nuclear debris, and there are so-called crescent tissue cells. Among the tissue cells, small lymphocytes, activated T cells and plasma cells can be seen, and a large number of tissue cells accumulate at the edge of necrosis. The isolated apoptotic cells are scattered in large tissue cells, mixed with cell debris and nuclear dust. In addition, plasmacytoid dendritic cells (pDCs) and immunoblasts can also be seen, thromboangiitis are distributed around the necrosis. Among them, the obvious lack of neutrophils, eosinophils and plasma cells are characteristic lesions and have great diagnostic value. The tissue cells in KFD are positive for lysozyme, myeloperoxidase, CD68, CD163 and CD4. The lymphocytes in the lesion are mainly T cells, mainly CD8. Compared with CD4, there are very few CD20-positive B cells [<xref ref-type="bibr" rid="scirp.116857-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.116857-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.116857-ref15">15</xref>]. A large number of CD8-positive cytotoxic T cells in lymphoid follicles are related to FDC network changes. The rich and distorted FDC network structure spans all morphological patterns, which can be regarded as important supporting diagnostic evidence for KFD [<xref ref-type="bibr" rid="scirp.116857-ref16">16</xref>]. According to histological characteristics, the researchers find that KFD can be divided into three histological patterns: hyperplasia, necrosis and xanthoma [<xref ref-type="bibr" rid="scirp.116857-ref17">17</xref>].</p><p>Patients can fully recover on their own within a few weeks to several months, while cervical lymphadenitis can last for 6 months to 1 year. Approximately 3% - 4% of adults can relapse, but studies have found that children with KFD have a higher recurrence rate of 42.4% [<xref ref-type="bibr" rid="scirp.116857-ref18">18</xref>]. Symptomatic and supportive treatment is an effective means to relieve symptoms of persistent fever and pain, including glucocorticoids, intravenous immunoglobulin, or hydroxychloroquine. Studies have found that removing the affected lymph nodes is effective for treatment [<xref ref-type="bibr" rid="scirp.116857-ref3">3</xref>]. Most KFD patients quickly relieve their symptoms after taking glucocorticoids. A small number of patients with severe illness or poor response to glucocorticoids can receive intravenous immunoglobulin [<xref ref-type="bibr" rid="scirp.116857-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.116857-ref20">20</xref>]. Hydroxychloroquine has also been used in the treatment of KFD, which has a certain effect on some patients with refractory KFD, but there is no clear guidance on the dosage and course of treatment [<xref ref-type="bibr" rid="scirp.116857-ref11">11</xref>]. The current research shows that the prognosis of children is usually better than that of adults. Although most patients with KFD have a good prognosis, there are also a few that can develop into other diseases, such as autoimmune hepatitis, SLE, Sjogren’s syndrome, hemophagocytic syndrome, mixed connective tissue disease, etc. have been reported. Therefore, long-term follow-up is required [<xref ref-type="bibr" rid="scirp.116857-ref21">21</xref>]. In a few cases, children with KFD may have neurological complications, such as meningoencephalitis, cerebellar ataxia, and encephalitis with central nervous system disease [<xref ref-type="bibr" rid="scirp.116857-ref22">22</xref>]. For patients with nervous system involvement, it is necessary to control intracranial pressure and convulsions. The sample size of this study is small, and the reference to children’s HNL is limited, and the sample size needs to be expanded for further study.</p></sec><sec id="s5"><title>5. Conclusion</title><p>As a rare disease, KFD has brought huge diagnostic challenges to clinicians. Due to the lack of specific clinical manifestations, laboratory examinations and imaging findings, most children will receive treatment for diseases such as anti-infection and anti-tuberculosis before diagnosis. What’s more, KFD is diagnosed by histopathology and immunohistochemical examination of the affected lymph nodes, and the removal of the affected lymph nodes has a therapeutic effect. Due to the self-limiting nature of the disease, most children have a good prognosis, but required long-term follow-up.</p></sec><sec id="s6"><title>Data Declaration</title><p>The authors confirm that no prior presentation of the study data as an abstract or poster has taken place.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Yuan, Y.L., Zhang, F. and Wang, T.M. (2022) Histiocytic Necrotizing Lymphadenitis: A Clinical Study of 6 Children and Literature Review. Open Journal of Clinical Diagnostics, 12, 19-26. https://doi.org/10.4236/ojcd.2022.122003</p></sec></body><back><ref-list><title>References</title><ref id="scirp.116857-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Khan, A.M., Ahmad, M., Muhammad, O., Taj, S. and Shiza, S.T. (2021) Kikuchi-Fujimoto Disease in a Young Female: A Case Report and Literature Review. Cureus, 13, e19321. https://doi.org/10.7759/cureus.19321</mixed-citation></ref><ref id="scirp.116857-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Perry, A.M. and Choi, S.M. (2018) Kikuchi-Fujimoto Disease: A Review. Archives of Pathology &amp; Laboratory Medicine, 142, 1341-1346. https://doi.org/10.5858/arpa.2018-0219-RA</mixed-citation></ref><ref id="scirp.116857-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Selvanathan, S.N., Suhumaran, S., Sahu, V.K., Chong, C.Y., Tan, N.W.H. and Thoon, K.C. (2020) Kikuchi-Fujimoto Disease in Children. Journal of Paediatrics and Child Health, 56, 389-393. https://doi.org/10.1111/jpc.14628</mixed-citation></ref><ref id="scirp.116857-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Tariq, H., Gaduputi, V., Rafiq, A. and Shenoy, R. (2014) The Enigmatic Kikuchi-Fujimoto Disease: A Case Report and Review. Case Reports in Hematology, 2014, Article ID: 648136. https://doi.org/10.1155/2014/648136</mixed-citation></ref><ref id="scirp.116857-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kang, H.M., Kim, J.Y., Choi, E.H., Lee, H.J., Yun, K.W. and Lee, H. (2016) Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children. The Journal of Pediatrics, 171, 208-12.E1. https://doi.org/10.1016/j.jpeds.2015.12.064</mixed-citation></ref><ref id="scirp.116857-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ahmed, Z., Quadir, H., Hakobyan, K., Gaddam, M., Kannan, A., Ojinnaka, U. and Mostafa, J.A. (2021) Kikuchi-Fujimoto Disease: A Rare Cause of Cervical Lymphadenopathy. Cureus, 13, e17021. https://doi.org/10.7759/cureus.17021</mixed-citation></ref><ref id="scirp.116857-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lelii, M., Senatore, L., Amodeo, I., Pinzani, R., Torretta, S., Fiori, S., Marchisio, P. and Bosis, S. (2018) Kikuchi-Fujimoto Disease in Children: Two Case Reports and a Review of the Literature. Italian Journal of Pediatrics, 44, Article No. 83. https://doi.org/10.1186/s13052-018-0522-9</mixed-citation></ref><ref id="scirp.116857-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Rosado, F.G.N., Tang, Y.W., Hasserjian, R.P., McClain, C.M., Wang, B. and Mosse, C.A. (2013) Kikuchi-Fujimoto Lymphadenitis: Role of Parvovirus B-19, Epstein-Barr Virus, Human Herpesvirus 6, and Human Herpesvirus 8. Human Pathology, 44, 255-259. https://doi.org/10.1016/j.humpath.2012.05.016</mixed-citation></ref><ref id="scirp.116857-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Chong, Y. and Kang, C.S. (2014) Causative Agents of Kikuchi-Fujimoto Disease (Histiocytic Necrotizing Lymphadenitis): A Meta-Analysis. International Journal of Pediatric Otorhinolaryngology, 78, 1890-1897. https://doi.org/10.1016/j.ijporl.2014.08.019</mixed-citation></ref><ref id="scirp.116857-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Pepe, F., Disma, S., Teodoro, C., Pepe, P. and Magro, G. (2016) Kikuchi-Fujimoto Disease: A Clinicopathologic Update. Pathologica, 108, 120-129.</mixed-citation></ref><ref id="scirp.116857-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Sope&amp;#241;a, B., Rivera, A., Chamorro, A., Freire, M., Alende, V., Seco, E., González-Gay, M.A. and González-Quintela, A. (2017) Clinical Association between Kikuchi’s Disease and Systemic Lupus Erythematosus: A Systematic Literature Review. Seminars in Arthritis and Rheumatism, 47, 46-52. https://doi.org/10.1016/j.semarthrit.2017.01.011</mixed-citation></ref><ref id="scirp.116857-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Tanaka, T., Ohmori, M., Yasunaga, S., Ohshima, K., Kikuchi, M. and Sasazuki, T. (1999) DNA Typing of HLA Class II Genes (HLA-DR, -DQ and -DP) in Japanese Patients with Histiocytic Necrotizing Lymphadenitis (Kikuchi’s Disease). Tissue Antigens, 54, 246-253. https://doi.org/10.1034/j.1399-0039.1999.540305.x</mixed-citation></ref><ref id="scirp.116857-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Han, H.J., Lim, G.Y., Yeo, D.M. and Chung, N.G. (2009) Kikuchi’s Disease in Children: Clinical Manifestations and Imaging Features. Journal of Korean Medical Science, 24, 1105-1109. https://doi.org/10.3346/jkms.2009.24.6.1105</mixed-citation></ref><ref id="scirp.116857-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Seong, H., Jeong, Y.H., Lee, W.J., Kim, J.H., Kim, J.H., Ahn, J.Y., Jeong, S.J., Choi, J.Y., Park, Y.S., Yeom, J.S., Song, Y.G., Cho, A. and Ku, N.S. (2021) Splenic Uptake on FDG PET/CT Correlates with Kikuchi-Fujimoto Disease Severity. Scientific Reports, 11, Article No. 10836. https://doi.org/10.1038/s41598-021-90350-z</mixed-citation></ref><ref id="scirp.116857-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Fidai, S.S., Cipriani, N.A. and Ginat, D.T. (2019) Histiocytic Necrotizing Lymphadenitis Involving the Neck: Radiology-Pathology Correlation. Head and Neck Pathology, 13, 648-651. https://doi.org/10.1007/s12105-018-0936-0</mixed-citation></ref><ref id="scirp.116857-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Sukswai, N., Jung, H.R., Amr, S.S., Ng, S.B., Sheikh, S.S., Lyapichev, K., El Hussein, S., Loghavi, S., Agbay, R.L.M.C., Miranda, R.N., Medeiros, L.J. and Khoury, J.D. (2020) Immunopathology of Kikuchi-Fujimoto Disease: A Reappraisal Using Novel Immunohistochemistry Markers. Histopathology, 77, 262-274. https://doi.org/10.1111/his.14050</mixed-citation></ref><ref id="scirp.116857-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hutchinson, C.B. and Wang, E. (2010) Kikuchi-Fujimoto Disease. Archives of Pathology &amp; Laboratory Medicine, 134, 289-293. https://doi.org/10.5858/134.2.289</mixed-citation></ref><ref id="scirp.116857-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Yoo, I.H., Na, H., Bae, E.Y., Han, S.B., Lee, S.Y., Jeong, D.C. and Kang, J.H. (2014) Recurrent Lymphadenopathy in Children with Kikuchi-Fujimoto Disease. European Journal of Pediatrics, 173, 1193-1199. https://doi.org/10.1007/s00431-014-2306-6</mixed-citation></ref><ref id="scirp.116857-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Yalcin, S., Toprak, S.K., Erismis, B., Altundag, O., Ozdemir, H. and Topcuoglu, N. (2011) Management of Kikuchi-Fujimoto Disease Using Glucocorticoid: A Case Report. Case Reports in Medicine, 2011, Article ID: 230840. https://doi.org/10.1155/2011/230840</mixed-citation></ref><ref id="scirp.116857-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Lin, D.Y., Villegas, M.S., Tan, P.L., Wang, S. and Shek, L.P. (2010) Severe Kikuchi’s Disease Responsive to Immune Modulation. Singapore Medical Journal, 51, E18-E21.</mixed-citation></ref><ref id="scirp.116857-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Vithoosan, S., Karunarathna, T., Shanjeeban, P., Piranavan, P., Matthias, T., Gamlaksha, D., Liyadipita, A. and Kulatunga, A. (2019) Kikuchi-Fujimoto Disease Associated with Systemic Lupus Erythematosus Complicated with Hemophagocytic Lymphohistiocytosis: A Case Report. Journal of Medical Case Reports, 13, Article No. 173. https://doi.org/10.1186/s13256-019-2100-1</mixed-citation></ref><ref id="scirp.116857-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Byun, J.H., Park, S.E., Nam, S.O., Kim, Y.A., Kim, Y.M., Yeon, G.M. and Lee, Y.J. (2018) Three Children of Meningoencephalitis with Kikuchi Necrotizing Lymphadenitis. Brain &amp; Development, 40, 251-255. https://doi.org/10.1016/j.braindev.2017.09.009</mixed-citation></ref></ref-list></back></article>